Intra-articular hyaluronic acid treatment for golfer's toe: Keeping older golfers on course

Physician and Sportsmedicine

Volumn 32, Issue 7, 2004, Pages 41-45

  Petrella, Robert J ^a,b   Cogliano, Anthony ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b Centre for Activity and Ageing   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; CORTICOSTEROID; HYALURONIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

AGED; ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISABILITY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; GOLFER TOE; HALLUX; HUMAN; INJECTION PAIN; JOINT MOBILITY; MALE; METATARSOPHALANGEAL JOINT; OSTEOARTHRITIS; OUTCOMES RESEARCH; PAIN ASSESSMENT; PAIN THRESHOLD; PATIENT SATISFACTION; PHYSICAL ACTIVITY; SCORING SYSTEM; VISUAL ANALOG SCALE;

EID: 3142580840     PISSN: 00913847     EISSN: None     Source Type: Journal    
DOI: 10.3810/psm.2004.07.453     Document Type: Article

References (16)

1. Creamer P, Hochberg MC: Osteoarthritis. Lancet 1997;350 (9076):503-508
2. Maheu E, Ayral X, Dougados M: A hyaluronan preparation (500-730 kDa) in the treatment of osteoarthritis: a review of clinical trials with Hyalgan. Int J Clin Pract 2002;56(10):804-813
3. Petrella RJ, DiSilvestro MD, Hildebrand C: Effects of hyaluronate sodium on pain and physical functioning in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled clinical trial. Arch Intern Med 2002;162 (3):292-298
4. Frizziero L, Govoni E, Bacchini P: Intra-articlar hyaluronic acid in the treatment of osteoarthritis of the knee: clinical and morphological study. Clin Exp Rheumatol 1998;16(4): 441-449
5. Altman RD, Moskowitz R: Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group. J Rheumatol 1998;25(11):2203-2212
6. Leardini G, Perbellini A, Franceschini M, et al: Intra-articular injections of hyaluronic acid in the treatment of painful shoulder. Clin Ther 1988;10(5):521-526
7. Spector TD, Cicuttini F, Baker J, et al: Genetic influences on osteoarthritis in women: a twin study. BMJ 1996;312(7036): 940-943
8. Kujala UM, Kaprio J, Sarna S: Osteoarthritis of weight bearing joints of lower limbs in former elite male athletes. BMJ 1994;308(6923):231-234
9. Carrabba M, Paresce E, Angelini M, et al: The safety and efficacy of different dose schedules of hyaluronic acid in the treatment of painful osteoarthritis of the knee with joint effusion. Eur J Rheumatol Inflam 1995;15:25-31
10. White WB, Whelton A: Cardiovascular events and COX-2 inhibitors. JAMA 2001;286(22):2811-2812
11. Johnson AG, Nguyen TV, Day RO: Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med 1994;121(4):289-300
12. Listrat V, Ayral X, Patarnello F, et al: Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan) in osteoarthritis of the knee. Osteoarthritis Cartilage 1997;5(3):153-160
13. Bellamy N, Kirwan J, Boers M, et al: Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis: consensus development at OMERACT III. J Rheumatol 1997;24(4): 799-802
14. Kotz R, Kolarz G: Intra-articular hyaluronic acid: duration of effect and results of repeated treatment cycles. Am J Orthop 1999;28(11 suppl):5-7
15. Pasquali Ronchetti I, Guerra D, Taparelli F, et al: Morphological analysis of knee synovial membrane biopsies from a randomized controlled clinical study comparing the effects of sodium hyaluronate (Hyalgan) and methylprednisolone acetate (Depomedrol) in osteoarthritis. Rheumatology (Oxford) 2001;40(2):158-169
16. Rovetta G, Monteforte P: Intraarticular injection of sodium hyaluronate plus steroid versus steroid in adhesive capsulitis of the shoulder. Int J Tissue React 1998;20(4):125-130